Photosensitive Epilepsy Clinical Trial
Official title:
A Multicenter, Single-blind, Within-subject, Placebo-controlled Proof of Concept Study to Assess the Effect of Single Oral Doses of BGG492 on the Photoparoxysmal EEG Response in Patients With Photosensitive Epilepsy
This study will evaluate the efficacy of BGG492 in reducing the sensitivity to flashing lights of patients with photosensitive epilepsy, using EEG as a readout.
n/a
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03239691 -
A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients
|
Phase 2 | |
| Terminated |
NCT03686033 -
A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy
|
Phase 2 | |
| Completed |
NCT00579384 -
A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy
|
Phase 2 | |
| Active, not recruiting |
NCT03790137 -
Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).
|
Phase 3 | |
| Completed |
NCT00894010 -
Photosensitivity Proof of Concept Trial
|
Phase 2 | |
| Completed |
NCT03580707 -
Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint
|
Phase 2/Phase 3 | |
| Terminated |
NCT03603639 -
A Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive Epilepsy
|
Phase 2 | |
| Completed |
NCT00609245 -
Effect of Valproic Acid Concentration on Photic Response
|
N/A |